FindTrial
Sign In

Neuroimmune mechanism in patients with primary trigeminal neuralgia

Neuroimmune mechanism in patients with primary trigeminal neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079216
Enrollment
Unknown
Registered
2023-12-27
Start date
2023-12-30
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal neuralgia

Interventions

Case group:None
Control group:None

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: From January 2023 to December 2023, the patient was hospitalized in the Department of Pain of our hospital for primary trigeminal neuralgia and underwent percutaneous puncture of microballoon compression surgery of the semilunar ganglion of the trigeminal nerve under general anesthesia.

Exclusion criteria

Exclusion criteria: Patients with other neurological diseases, uncontrolled mental disorders and communication disorders, pregnancy, and definitely refused telephone follow-up

Design outcomes

Primary

MeasureTime frame
Prolactin;Growth hormone;Galectin-3;—

Secondary

MeasureTime frame
Total cholesterol;Triglycerides;Low density lipoprotein;High density lipoprotein;—

Countries

China

Contacts

Public ContactHong Liu

The First Affiliated Hospital of Soochow University

isabella-liu@163.com+86 139 1310 8009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026